Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Paolo Tarantino; Giuseppe Curigliano

doi:10.1056/NEJMc2021840

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Istituto Europeo di Oncologia

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	694-695
Number of pages	2
Journal	The New England journal of medicine
Volume	383
Issue number	7
DOIs	https://doi.org/10.1056/NEJMc2021840
Publication status	Published - Aug 13 2020

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc2021840

Cite this

@article{bda5b4dc89fb49c0bfb454b5e5f74669,

title = "Atezolizumab and Bevacizumab in Hepatocellular Carcinoma",

author = "Paolo Tarantino and Giuseppe Curigliano",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2020",

month = aug,

day = "13",

doi = "10.1056/NEJMc2021840",

language = "English",

volume = "383",

pages = "694--695",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

AU - Tarantino, Paolo

AU - Curigliano, Giuseppe

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2020/8/13

Y1 - 2020/8/13

UR - http://www.scopus.com/inward/record.url?scp=85089407858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089407858&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2021840

DO - 10.1056/NEJMc2021840

M3 - Letter

C2 - 32786200

AN - SCOPUS:85089407858

VL - 383

SP - 694

EP - 695

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 7

ER -

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this